Neuropace, Inc. (NASDAQ: NPCE)
$12.4000
+0.8300 ( +6.44% ) 17.5K
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.
Market Data
Open
$12.4000
Previous close
$11.5700
Volume
17.5K
Market cap
$345.64M
Day range
$11.3010 - $12.4490
52 week range
$5.4500 - $18.1500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 15 | Nov 12, 2024 |
| 10-q | Quarterly Reports | 64 | Nov 12, 2024 |
| 4 | Insider transactions | 1 | Oct 28, 2024 |
| 4 | Insider transactions | 1 | Oct 24, 2024 |
| 4 | Insider transactions | 1 | Oct 22, 2024 |
| 4 | Insider transactions | 1 | Oct 18, 2024 |
| 4 | Insider transactions | 1 | Oct 03, 2024 |
| 8-k | 8K-related | 15 | Aug 13, 2024 |
| 10-q | Quarterly Reports | 64 | Aug 13, 2024 |
| 4 | Insider transactions | 2 | Jun 11, 2024 |